Long-term developmental progression in infants and young children taking sapropterin for phenylketonuria: a two-year analysis of safety and efficacy.
about
New Strategies for the Treatment of Phenylketonuria (PKU)Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trialThe complete European guidelines on phenylketonuria: diagnosis and treatment.Diagnostic and therapeutic recommendations for the treatment of hyperphenylalaninemia in patients 0-4 years of age
P2860
Long-term developmental progression in infants and young children taking sapropterin for phenylketonuria: a two-year analysis of safety and efficacy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Long-term developmental progre ...... alysis of safety and efficacy.
@en
Long-term developmental progre ...... alysis of safety and efficacy.
@nl
type
label
Long-term developmental progre ...... alysis of safety and efficacy.
@en
Long-term developmental progre ...... alysis of safety and efficacy.
@nl
prefLabel
Long-term developmental progre ...... alysis of safety and efficacy.
@en
Long-term developmental progre ...... alysis of safety and efficacy.
@nl
P2093
P2860
P356
P1433
P1476
Long-term developmental progre ...... nalysis of safety and efficacy
@en
P2093
Annette Feigenbaum
Barbara K Burton
Charlie Zhang
Elaina Jurecki
Komudi Siriwardena
Nicola Longo
Susan Waisbren
Suyash Prasad
Sylvia Stockler
William Lang
P2860
P2888
P304
P356
10.1038/GIM.2014.109
P407
P577
2014-09-18T00:00:00Z